About Us

arrow-icon
Back to About Us
member-photo-1

George Delgado, M.D., F.A.A.F.P.

Guest Contributor

Dr. George Delgado is the medical director of Abortion Pill Reversal (APR) and of Culture of Life Family Health Care.

Dr. Delgado published the first peer-reviewed article in the medical literature describing the reversal of mifepristone (RU 486) using progesterone. He then established Abortion Pill Reversal, a program that connects women who have changed their minds after taking mifepristone (RU 486) and want to reverse the effects of the abortion pill. APR also seeks to refine and improve the treatment protocols for reversing mifepristone.

Dr. Delgado received his medical degree from the University of California, Davis and completed his residency at Santa Monica Hospital/UCLA. He is board certified in family medicine and in hospice and palliative medicine. Dr. Delgado is an NFP Medical Consultant trained in NaProTechnology. He completed the one-year Certification Program in Health Care Ethics with the National Catholic Bioethics Center.

He is an experienced, popular speaker who has made hundreds of presentations to a wide variety of audiences including pro-life fund raisers. His topics include APR, abortion, euthanasia, stem cell research, cloning, personhood, other bioethical issues, NaProTECHNOLOGY and natural family planning. Dr. Delgado is a regular guest on Catholic Answers Live, the most widely heard show on Catholic radio. He and his wife Liz were selected to receive the St. Gianna Molla Pro-Life Award at the 2017 Walk for Life West Coast.

Dr. Delgado and his wife Liz have four children and one grandchild.

Latest Research & News

  • Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines | September 30, 2020

    To view this chart as a PDF, see: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines   Updated November 11, 2020   Accurate information about the development and production of COVID-19 vaccines is essential, especially because many proposed candidates use newer molecular technologies for production of a viral vaccine. One concern regarding the ethical assessment of […]

  • A Visual Aid to Viral Infection and Vaccine Production | June 15, 2020

    This is Issue 1 in CLI’s On Science. To view this report as a PDF, see: A Visual Aid to Viral Infection and Vaccine Production   Updated November 2020   Introduction As a result of the rapid spread of the new coronavirus technically known as SARS-CoV-2, the United States and other governments have begun crash […]

  • The Coronavirus Pandemic and the Ethics of Triage | March 26, 2020

    by R. J. Snell, Ph.D. This paper can be viewed as a pdf here: The Coronavirus Pandemic and the Ethics of Triage   As the COVID-19 pandemic continues in Italy, many hospitals are overwhelmed with patients, necessitating difficult triage decisions that can seem like choosing who lives and who dies. In the United States, already […]

  • Pro-Life Topics for Lawmakers Regarding Coronavirus | March 25, 2020

    This is Issue 43 in CLI’s On Point Series. To view this report as a PDF, see: On Point 43 Pro-Life Topics for Lawmakers Regarding Coronavirus.   Abortion advocates have found a new ally—COVID-19.   During this intensely stressful time, the vast majority of Americans are focused on protecting their health and the health of […]

  • Written Testimony of George Delgado, M.D., F.A.A.F.P., in Support of Colorado Abortion Pill Reversal Bill | February 16, 2017

    On Thursday, February 9, 2017, the Colorado House Health, Insurance and Environment Committee held a hearing regarding House Bill 1086 (HB 1086), the Abortion Pill Reversal Information Act. HB 1086 provides that prior to initiating a chemical abortion, a physician must alert the woman to the fact that it may be possible to reverse the abortion should she change her mind and that information on the possibility of reversal is available in state-prepared materials.